Anthony Hunt sold $3.4M of RGEN
director at REPLIGEN CORP. 24,246 shares at an average of $139.67, traded Nov 21, 2024, filed Nov 22, 2024.
Score components
- +15RoleDirector
- +25Trade size$3.4M at market
- +5Share of holdings soldSold 15% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-130266, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 21, 2024 | MOption exercise Common Stock | +24,246 | $33.87 | $821k | 164,086 | Nov 22, 2024 |
| Nov 21, 2024 | SOpen-market sale Common Stock | -24,246 | $139.67 | $3.4M | 139,840 | Nov 22, 2024 |
| Nov 21, 2024 | MOption exercise Stock Option (Right to Buy)derivative | +24,246 | $0.00 | $0 | 0 | Nov 22, 2024 |
Related signals
Other insiders at REPLIGEN CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $1.0M 5,535 shares | -12% | |
| 20Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $2.5M 12,946 shares | -23% | |
| 20Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $977k 5,426 shares | -10% | |
| 23Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $504k 3,035 shares | -6% | |
| 25Weak | REPLIGEN CORP | Anthony Hunt director | $3.3M 26,447 shares | -19% | |
| 10Weak | REPLIGEN CORP | Anthony Hunt director | $4.1M 26,756 shares | -16% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.